Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Sonrotoclax · Beqalzi, BGB-11417

Small molecule · Inhibitor of B-cell lymphoma 2 (BCL-2) protein (BCL2) · developed by Beone Medicines Usa

Approved FDA, May 2026
ONC Developer
2 Registered trials

What is Sonrotoclax?

Sonrotoclax is an orally bioavailable BCL-2 inhibitor that binds the anti-apoptotic protein B-cell lymphoma 2 and displaces pro-apoptotic proteins, restoring apoptosis in BCL-2-overexpressing cancer cells.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Beqalzi, BGB-11417
Drug type
Small molecule
Targets
B-cell lymphoma 2 (BCL-2) protein (BCL2)
Mechanism
Inhibitor of B-cell lymphoma 2 (BCL-2) protein (BCL2)
Pathways
intrinsic apoptosis, caspase activation
Therapy area
Oncology
Developer
Beone Medicines Usa (ONC)
FDA status
Approved as Beqalzi (May 13, 2026), NDA220711 · FDA label
UNII
30R67U9KYS

✅ FDA-approved uses

From the indications section of the FDA label (version of Jul 27, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT06073821 Phase 3 CLL Active not recruiting ONC
NCT07628881 Phase 1 Healthy Volunteers Completed ONC

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

CLLHealthy Volunteers

Other drugs acting on BCL2

More from Beone Medicines Usa

Sources

Updated Nov 15, 2026. Something wrong or missing? Report it on the ONC page.

Follow ONC, the company behind Sonrotoclax

See ONC's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

ONC catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.